返回首頁 > 醫師介紹
姓名: 黃昭誠(Huang Chao-Cheng)
學歷: 高雄醫學院醫學系畢業
經歷:
現職: 教授級主治醫師
教職: 長庚大學專任教授
信箱:
研究計畫:

近期研究計畫:

  1. Study on the differential expression of exosomal miRNA between HPV-positive and HPV-negative head and neck squamous cell carcinoma. Chang Gung Medical Research Proposal, CMRPG8G1271 (01/01/2018 - 12/31/2018).
  2. Evaluation of DLK1 as a prognostic and chemoresistance biomarker of ovarian serous carcinomas. Ministry of Science and Technology Proposal, MOST 107-2320-B-182-037-MY3 (08/01/2018 - 07/31/2021).
  3. Evaluation of the scoring agreement of immunohistochemistry for Ventana SP263 PD-L1 antibody on non-small cell lung cancer, head and neck squamous cell cancer and urothelial carcinoma, and the comparison of Ventana SP263 PD-L1 antibody and DAKO PharmDx 22C3 PD-L1 antibody on non-small cell lung cancer - International IO Ring Study. Chang Gung Clinical Trial Proposal, XMRPG8H0421 (08/22/2018 - 06/30/2019).
  4. Delineating the role of Delta-like non-canonical Notch ligand 1 (DLK1) in liver fibrosis. Chang Gung-Zhongshan Conjoint Medical Research Proposal, CMRPG8I0281 (01/01/2019 - 12/31/2019).

 

重要著作:

近年重要著作:

  1. Huang CC*, Cheng SH, Wu CH, Li WY, Wang JS, Kung ML, Chu TH, Huang ST, Feng CT, Huang SC, Tai MH*. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling. Oncogene 2019 April 38:3201-3215.  (SCI) (First author and *co-corresponding author)
  2. Huang CC*, Kuo HM*, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC, Chuang JH, Tai MH. Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch 1/Akt/eNOS signaling in endothelial cells. Angiogenesis 2018, 21:299-312   (SCI) (*Co-first author)
  3. Rau KM, Chen HK, Shiu LY, Chao TL, Lo YP, Wang CC, Lin MC, Huang CC*. Discordance of mutation statuses of epidermal growth factor receptor and K-ras between primary adenocarcinoma of lung and brain metastasis. Int J Mol Sci 2016 Apr;17(4): E524.  (SCI) (Corresponding author)
  4. Lin LL*, Huang CC*, Wu CL, Wu MT, Hsu WM, Chuang JH. Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts. Lab Invest 2016 May 16 [Epub ahead of print].  (SCI) (*Co-first author)
  5. Huang CC*, Wang SY*, Lin LL, Wang PW, Chen TY, Hsu WM, Lin TK, Liou CW, Chuang JH. Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth. Dis Model Mech 2015 Oct;8(10):1247-1254.  (SCI) (*Co-first author)
  6. Huang EY, Chanchien CC, Lin H, Wang CC, Wang CJ, Huang CC*. Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2013 Dec;87(5):975-982.  (SCI) (Corresponding author)
  7. Hsu WM*, Huang CC*, Wu PY, Lee H, Huang MC, Tai MH, Chuang JH. Toll-like receptor 3 expression inhibits cell invasion and migration and predicts a favorable prognosis in neuroblastoma. Cancer Lett 2013 Aug;336(2):338-346.  (SCI) (*Co-first author)
  8. Lu MH*, Huang CC*, Pan MR*, Chen HH, Hung WC. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Clin Cancer Res 2012 Dec;18(23):6416-6425.  (SCI) (*Co-first author)
  
版權所有 © 網站內容為高雄長庚紀念醫院解剖病理部 所有   網站最佳瀏覽解析度為 1024X768  Designed by D-Spring
高雄市鳥松區大埤路 123 號3樓 TEL:(07)731-7123轉2100 FAX:(07)733-3198
網頁負責人:李瀅代 最新更新日期:2024年07月01日